Kenneth Kaitin - Director, Curis Inc

As of January 29, 2021


Kenneth Kaitin Net Worth

  • Net worth is estimated to be at least $250.08K
  • Owns at least 28,121 units of Curis Inc stock
  • Sold an estimated value of $62.84K in the last 17 years at Curis Inc

Kenneth Kaitin Trading

  • Largest purchase of shares was 15,000 units , worth over $25.05K on May 27, 2016
  • Largest sale of shares was 15,000 units , worth over $26.4K on May 27, 2016
  • In total has made about 23 transactions over 17 years
  • Usually trades in January, with the busiest year in 2011, 2004, 2017, 2019 and 2016
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Kenneth Kaitin Mailing Address

  • Mailing address is C/o Tufts Cntr For the Study of Drug Dev 75 Kneeland St, Suite 1100 Boston MA 02111 MA

Curis Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
James E. Dentzer 2020 $544,900 - $627,075 $476,685 $14,189 $1,672,849
James E. Dentzer 2019 $509,507 - $849,513 $183,547 $15,206 $1,557,773
James E. Dentzer 2018 $479,383 $142,313 $1,031,405 $297,000 $14,635 $1,964,736
Robert E. Martell, M.D., Ph.D. 2020 $366,091 - $321,899 $261,954 $11,401 $961,345
Robert E. Martell, M.D., Ph.D. 2019 $342,245 - $294,620 $128,429 $11,200 $776,494
Robert E. Martell, M.D., Ph.D. 2018 $186,712 $127,650 $475,377 $124,688 $26,042 $940,469
William E. Steinkrauss 2020 $352,135 - $321,899 $201,960 $15,761 $891,755
William E. Steinkrauss 2019 $284,301 - $248,875 $91,501 $65,488 $690,165
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1108205/000119312521116336/d88919ddef14a.htm

Curis Inc Insider Trading

  • The most recent transaction was 5,377 units sold on January 26, 2021 by James Dentzer worth over $57.78K
  • In the last 18 years, insiders at Curis Inc sold an estimated value of $21.29M and bought an estimated value of $31.45M
  • The most active traders are James McNab, Director,  Daniel Passeri, Director,  and Martyn Greenacre, Director
  • Insider trading is most common in January, with the busiest year in 2004
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1